231 related articles for article (PubMed ID: 15937548)
1. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
Han B; Serra P; Yamanouchi J; Amrani A; Elliott JF; Dickie P; Dilorenzo TP; Santamaria P
J Clin Invest; 2005 Jul; 115(7):1879-87. PubMed ID: 15937548
[TBL] [Abstract][Full Text] [Related]
2. Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
Marée AF; Santamaria P; Edelstein-Keshet L
Int Immunol; 2006 Jul; 18(7):1067-77. PubMed ID: 16728432
[TBL] [Abstract][Full Text] [Related]
3. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population.
Amrani A; Verdaguer J; Serra P; Tafuro S; Tan R; Santamaria P
Nature; 2000 Aug; 406(6797):739-42. PubMed ID: 10963600
[TBL] [Abstract][Full Text] [Related]
4. Autoantigen recognition is required for recruitment of IGRP(206-214)-autoreactive CD8+ T cells but is dispensable for tolerance.
Wang J; Tsai S; Han B; Tailor P; Santamaria P
J Immunol; 2012 Sep; 189(6):2975-84. PubMed ID: 22908330
[TBL] [Abstract][Full Text] [Related]
5. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
Han B; Serra P; Amrani A; Yamanouchi J; Marée AF; Edelstein-Keshet L; Santamaria P
Nat Med; 2005 Jun; 11(6):645-52. PubMed ID: 15908957
[TBL] [Abstract][Full Text] [Related]
6. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
7. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
Khadra A; Santamaria P; Edelstein-Keshet L
J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
[TBL] [Abstract][Full Text] [Related]
8. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes.
Kishi M; Yasuda H; Abe Y; Sasaki H; Shimizu M; Arai T; Okumachi Y; Moriyama H; Hara K; Yokono K; Nagata M
Biochem Biophys Res Commun; 2010 Mar; 394(1):228-32. PubMed ID: 20206130
[TBL] [Abstract][Full Text] [Related]
9. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
10. On how monospecific memory-like autoregulatory CD8+ T cells can blunt diabetogenic autoimmunity: a computational approach.
Khadra A; Tsai S; Santamaria P; Edelstein-Keshet L
J Immunol; 2010 Nov; 185(10):5962-72. PubMed ID: 20962260
[TBL] [Abstract][Full Text] [Related]
11. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity.
Heath WR; Karamalis F; Donoghue J; Miller JF
J Immunol; 1995 Sep; 155(5):2339-49. PubMed ID: 7650369
[TBL] [Abstract][Full Text] [Related]
13. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
14. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
[TBL] [Abstract][Full Text] [Related]
15. How the immune system achieves self-nonself discrimination during adaptive immunity.
Jiang H; Chess L
Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma.
Zwicker K; Chatten C; Gratton K; Demetrick D; Serra P; Shameli A; Santamaria P; Bathe OF
J Immunol; 2009 Aug; 183(3):1705-14. PubMed ID: 19570832
[TBL] [Abstract][Full Text] [Related]
17. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
[TBL] [Abstract][Full Text] [Related]
18. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP; Li L; Frelinger JA; Tisch R
J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
[TBL] [Abstract][Full Text] [Related]
19. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent.
Shameli A; Clemente-Casares X; Wang J; Santamaria P
J Immunol; 2011 Sep; 187(6):2859-66. PubMed ID: 21824864
[TBL] [Abstract][Full Text] [Related]
20. Reversal of autoimmunity by boosting memory-like autoregulatory T cells.
Tsai S; Shameli A; Yamanouchi J; Clemente-Casares X; Wang J; Serra P; Yang Y; Medarova Z; Moore A; Santamaria P
Immunity; 2010 Apr; 32(4):568-80. PubMed ID: 20381385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
